Summary statistics of essential health services utilization from July 2019 to October 2020 in Addis Ababa, Ethiopia. by Admas Abera (11821659)

Subjects:

Trends of expanded immunization program in Addis Ababa Ethiopia from July 2019 to October 2020. by Admas Abera (11821659)

Subjects:

Trends of COVID-19 pandemic on essential health services in Addis Ababa, Ethiopia, from July 2019 to October 2020. by Admas Abera (11821659)

Subjects:

Summary of person-years, deaths, median age at death, crude mortality rates, age- and sex-standardised mortality rates (per 1,000 person-years), and standardised mortality ratios (... by Luís-Jorge Amaral (16406704)

Subjects:

ZIP file containing the 3 datasets used during analysis: 1) Epilepsy suspected and mortality data; 2) Epilepsy confirmed data; 3) anti-Ov16 seroprevalence data per study site. by Luís-Jorge Amaral (16406704)

Subjects:

Relationship between age- and sex-standardised anti-Ov16 seroprevalence in children aged 3‒9 years and age- and sex-standardised confirmed prevalence of epilepsy (A) and probable n... by Luís-Jorge Amaral (16406704)

Subjects:

Location of (A) South Sudan and (B) study counties (Maridi, Mundri East, Mundri West, Mvolo and Wulu). by Luís-Jorge Amaral (16406704)

Subjects:

Classification of study villages according to their distance from rivers with confirmed vector (<i>Simulium damnosum</i> sensu lato) breeding grounds for the five South Sudanese st... by Luís-Jorge Amaral (16406704)

Subjects:

Epilepsy, including probable nodding syndrome (pNS), and pNS prevalence per study county in high- and low-risk sites in South Sudan. by Luís-Jorge Amaral (16406704)

Subjects:

Table 1_Pandemic predisposing influence for feline lower urinary disorders.xlsx by Carolina C. L. Paulino (21546620)

“…The DP group demonstrated a statistically significant decrease in relapses (p < 0.001) and mortality (p < 0.05) compared to the BP group. …”

Table 2_Pandemic predisposing influence for feline lower urinary disorders.xlsx by Carolina C. L. Paulino (21546620)

“…The DP group demonstrated a statistically significant decrease in relapses (p < 0.001) and mortality (p < 0.05) compared to the BP group. …”

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

a) ECM components and collagen structure change with tumor progression, which influences cancer cell proliferation and metastasis. b) SHG visual representation of collagen patterns... by Zoë Dinkel (21402766)

Table 3_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.docx by Linda S. Barter (21466916)